Life Sciences (Pharma & Medtech)
Entry Strategy into Cell Therapy Reagent Market: Global
Client Challenge
The client, a leading Indian company specializing in polyclonal antibodies, native human antigens, and diagnostic kits, sought to explore the Cell Therapy reagent market for CAR-T and TCR therapies. With a strong global presence, the client wanted to assess the reagent landscape in the USA and Europe
The primary challenge was to shortlist the reagents used in CAR-T and TCR therapies to better understand the market dynamics and identify the most promising opportunities for future involvement
Our Approach
- Conducted a comprehensive market sizing analysis for CAR-T and TCR therapies and reagents, segmenting by therapeutic areas like oncology, and projected growth rates for key reagent categories (e.g., antibodies, cytokines, viral vectors etc.) in the USA and Europe to pinpoint high-growth opportunities
- Identified market drivers such as research advancements, rising demand for cell-based therapies, and supportive regulations, while assessing barriers including regulatory hurdles that could impact reagent adoption and market penetration
- Mapped CAR-T and TCR therapy workflows, categorizing reagents by usage frequency and required quantities at commercial and research levels to gauge demand at different manufacturing/ developmental stages
- Evaluated reagent costs at each therapy step, factoring in pricing and consumption, and analyzed key suppliers’ product offerings, pricing strategies
- Shortlisted reagents based on client capabilities, growth potential, regulatory requirements, competitive landscape, pricing, and profitability, prioritizing options aligned with the client’s strategic objectives and market opportunities
Our Impact
By focusing on reagent shortlisting and market sizing, we helped the client gain a deeper understanding of the CAR-T and TCR therapy reagent market. Our insights into market dynamics, growth drivers, cost structures, and competitive landscape provided the client with a foundation for strategic planning of their product portfolio